摘要
目的探讨血红素氧化酶-1(HO-1)在人表浅性膀胱癌中的表达及意义。方法应用免疫组织化学链霉菌抗生物素蛋白一过氧化物酶(SP)法检测46例初发表浅性膀胱癌,其中术后复发组21例,术后无复发组25例以及8例正常膀胱组织中HO-1的表达,比较3组之间及膀胱癌不同病理分级之间的差异。结果46例膀胱癌组织中38例(82.6%)呈阳性表达,而8例正常膀胱组织中仅1例阳性表达,差异有统计学意义(P〈0.05),其中21例复发组膀胱癌95.2%阳性表达,26例无复发组膀胱癌中72.0%阳性表达,HO-1表达在有无复发组间差异有统计学意义(P〈0.05)。HO-1的阳性细胞表达在不同病理分级间差异有统计学意义(P〈0.05)。结论HO-1蛋白的表达可能与表浅性膀胱癌的发生、发展和复发有关。
Objective To investigate the expression profile of heme oxygenase-1 in human superfi- cial bladder cancer. Methods The expression of heme oxygenase-1 ( HO-1 ) was detected by using immu- nohistochemical streptavid-in-peroxidase (SP) method in 46 cases of initial onset of superficial bladder cancer [ including postoperative recurrence group ( n -- 21 ) and postoperative no-recurrence group ( n -- 25 ) 1 , and 8 cases of normal bladder tissues. A comparison was made between recurrence group and no-re- currence group, and among the pathological grades. Results The positive rate of HO-1 protein in human bladder carcinoma was 82. 6% , significantly higher than that in the normal bladder tissues ( 12. 5%, P 〈 O. 05 ). There was significant difference in the expression of HO-1 between tissues of bladder carcinoma without recurrence and tissues of bladder carcinoma with recurrence ( P 〈 0. 05 ). There was significant difference in the expression of HO-1 among the pathological grades ( P 〈 0. 05 ). Conclusion The HO-1 expression may play an important role in the development, and recurrence of superficial bladder carcinoma.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2012年第12期2391-2392,I0002,I0003,共4页
Chinese Journal of Experimental Surgery